Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2020

Feb 19, 2020

29777_dirs_2020-02-19_1ddf76f1-0c37-402a-be9b-2ee72884c527.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-02-16

Reporting Person: Moreland Mary K (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-16 Common shares without par value F 1020 $89.66 Disposed 55008 Direct
2020-02-17 Common shares without par value F 1004 $89.66 Disposed 54004 Direct
2020-02-19 Common shares without par value S 1019 $88.97 Disposed 52985 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 10673 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2020.